156 related articles for article (PubMed ID: 18270432)
21. Systematic search for single nucleotide polymorphisms in the insulin gene: evidence for a high frequency of -23T-->A in Japanese subjects.
Osawa H; Onuma H; Murakami A; Ochi M; Nishimiya T; Kato K; Shimizu I; Fujii Y; Ohashi J; Makino H
Biochem Biophys Res Commun; 2001 Aug; 286(3):451-5. PubMed ID: 11511079
[TBL] [Abstract][Full Text] [Related]
22. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
23. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
24. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population.
Inazu A; Nishimura Y; Terada Y; Mabuchi H
J Hum Genet; 2001; 46(4):172-7. PubMed ID: 11322655
[TBL] [Abstract][Full Text] [Related]
25. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects.
Johansson LM; Johansson LE; Ridderstråle M
Metabolism; 2008 Nov; 57(11):1558-62. PubMed ID: 18940394
[TBL] [Abstract][Full Text] [Related]
26. Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.
Saddi-Rosa P; Oliveira C; Crispim F; Giuffrida FM; de Lima V; Vieira J; Doria A; Velho G; Reis A
Cardiovasc Diabetol; 2013 Aug; 12():119. PubMed ID: 23968400
[TBL] [Abstract][Full Text] [Related]
27. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
Lu H; Inazu A; Moriyama Y; Higashikata T; Kawashiri MA; Yu W; Huang Z; Okamura T; Mabuchi H
J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
[TBL] [Abstract][Full Text] [Related]
28. A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease.
Wang LS; Yan JJ; Tang NP; Zhu J; Wang YS; Wang QM; Tang JJ; Wang MW; Jia EZ; Yang ZJ; Huang J
Mol Biol Rep; 2011 Feb; 38(2):819-25. PubMed ID: 20383745
[TBL] [Abstract][Full Text] [Related]
29. A common P2 promoter polymorphism of the hepatocyte nuclear factor-4alpha gene is associated with insulin secretion in non-obese Japanese with type 2 diabetes.
Tokunaga A; Horikawa Y; Fukuda-Akita E; Okita K; Iwahashi H; Shimomura I; Takeda J; Yamagata K
Endocr J; 2008 Dec; 55(6):999-1004. PubMed ID: 18654034
[TBL] [Abstract][Full Text] [Related]
30. Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.
Osawa H; Niiya T; Onuma H; Murakami A; Ochi M; Nishimiya T; Ogura T; Kato K; Shimizu I; Fujii Y; Ohashi J; Yamada K; Liang SJ; Manganiello VC; Fujita-Yamaguchi Y; Makino H
Mol Genet Metab; 2003 May; 79(1):43-51. PubMed ID: 12765845
[TBL] [Abstract][Full Text] [Related]
31. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
[TBL] [Abstract][Full Text] [Related]
32. A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia.
Ono S; Ezura Y; Emi M; Fujita Y; Takada D; Sato K; Ishigami T; Umemura S; Takahashi K; Kamimura K; Bujo H; Saito Y
J Hum Genet; 2003; 48(9):447-450. PubMed ID: 12955585
[TBL] [Abstract][Full Text] [Related]
33. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians.
Konheim YL; Wolford JK
Hum Genet; 2003 Oct; 113(5):377-81. PubMed ID: 12920574
[TBL] [Abstract][Full Text] [Related]
34. A novel functional polymorphism (-336A/G) in the promoter of the partitioning-defective protein-6alpha gene is associated with increased glucose tolerance and lower concentrations of serum non-esterified fatty acids.
Weyrich P; Lammers R; Fritsche A; Machicao F; Häring HU; Stefan N
Diabetologia; 2005 Apr; 48(4):669-74. PubMed ID: 15744531
[TBL] [Abstract][Full Text] [Related]
35. The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.
Osawa H; Yamada K; Tabara Y; Ochi M; Onuma H; Nishida W; Shimizu I; Kawamoto R; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):36-44. PubMed ID: 18036196
[TBL] [Abstract][Full Text] [Related]
36. Macrostemonoside A promotes visfatin expression in 3T3-L1 cells.
Zhou H; Yang X; Wang NL; Zhang YO; Cai GP
Biol Pharm Bull; 2007 Feb; 30(2):279-83. PubMed ID: 17268065
[TBL] [Abstract][Full Text] [Related]
37. C-514T polymorphism in hepatic lipase gene promoter is associated with elevated triglyceride levels and decreasing insulin sensitivity in nondiabetic Japanese subjects.
Yabu Y; Noma K; Nakatani K; Nishioka J; Suematsu M; Katsuki A; Hori Y; Yano Y; Sumida Y; Wada H; Nobori T
Int J Mol Med; 2005 Sep; 16(3):421-5. PubMed ID: 16077949
[TBL] [Abstract][Full Text] [Related]
38. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
39. Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals.
Shin HD; Park KS; Park BL; Cheong HS; Cho YM; Lee HK; Lee JY; Lee JK; Kim HT; Han BG; Kim JW; Koh I; Kim YJ; Oh B; Kimm K; Park C
Diabet Med; 2006 Jan; 23(1):72-6. PubMed ID: 16409569
[TBL] [Abstract][Full Text] [Related]
40. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
